Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs LNT✓SelectedUSD · LNTGSK vs LNT performance historyLatest closeAs of-1.93%09/04
Stock and ETF performance explorer

GSK vs LNT

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+1,705.8%
LNT return
+3,155.8%
Excess return
-1,450.0%
Maximum drawdown
-55.2%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioLNTExcessAlpha
1D-1.9%0.0%-1.9%-1.9%
7D-1.8%-0.1%-1.7%-1.8%
30D-2.2%-3.2%+1.0%-1.2%
3M-1.8%-4.1%+2.3%-0.5%
6M-10.6%-4.6%-6.0%-9.3%
YTD+4.4%+7.0%-2.6%+2.0%
1Y+30.4%+8.3%+22.1%+26.8%
3Y+60.1%+51.0%+9.1%+38.7%
5Y+46.8%+30.2%+16.6%+32.0%
10Y+79.2%+143.6%-64.4%+29.2%
All+1,705.8%+3,155.8%-1,450.0%+438.4%

Cumulative growth

Daily Returns

Daily percentage return beside LNT.

Daily Out/Under-Performance

Portfolio return minus LNT return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × LNT return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded LNT wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling